on Relief Therapeutics Holding SA (ETR:RLF)
MindMaze Completes Simplification, Updates on Neuro.io Financing
MindMaze Therapeutics Holding SA has announced the completion of its organizational simplification and provided updates on its equity financing with Neuro.io Group SA. Based in Geneva, Switzerland, the company aims to focus on its core business in neurotherapeutics by divesting non-neurology legacy operations. This reorganization aims to streamline operations and reduce costs.
On the financing front, MindMaze has completed the first tranche of its CHF 8 million initiative with Neuro.io, receiving CHF 4 million and issuing new shares. They plan to complete the remaining CHF 4 million across two installments in September and November 2026. While working to finalize this investment, MindMaze is also seeking additional financing to support its liquidity needs.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Relief Therapeutics Holding SA news